NCT01617460View on ClinicalTrials.gov

A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Autistic Disorder
Interventions
DRUG

Aripiprazole

Flexibly dose administered orally once daily

Trial Locations (5)

Unknown

Chubu Region

Chugoku Region

Kanto Region

Kinki Region

Kyushu Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY